Lasa Supergenerics gets patents for its key products for 20 years

05 Dec 2019 Evaluate

Lasa Supergenerics has been granted patents for its key products for the period of 20 years. The company has been granted patents for ‘An improved process for the preparation of Methyl 5-(Propylthio)-1h-Benzo [D] Imidazol-2-Ylcarbanate’ and ‘Process for the preparation of Benzimidazole Derivative as Anthelmintic Agents.’ Till date the company has been successfully granted 6 patents and rest 2 are in pipeline.

Lasa Supergenerics, pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×